Long-Term, Real-World Survival Excellent for Surgical Aortic Valve Replacement
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 24, 2023 -- In low-risk patients, long-term survival following surgical aortic valve replacement (SAVR) remains excellent, according to a study published online Oct. 17 in the Annals of Thoracic Surgery.
Vinod H. Thourani, M.D., from Piedmont Healthcare in Atlanta, and colleagues examined long-term, real-world outcomes of 42,586 low-risk patients undergoing SAVR (2011 to 2019).
The researchers found that the mean predicted risk for mortality (PROM) was 1.9 percent. In a time-to-event analysis, all-cause mortality was 2.6 percent at one year, 4.5 percent at three years, 7.1 percent at five years, and 12.4 percent at eight years. Survival was significantly better for patients with lower PROM, younger versus older age, and higher versus lower left ventricular ejection fraction. The eight-year survival following SAVR was 95 percent when PROM was less than 1 percent or the patient age was younger than 75 years.
“These contemporary longitudinal data serve to aid in the balanced interpretation of current and future trials comparing SAVR and transcatheter aortic valve replacement and may assist in the clinical decision-making process for patients of lower surgical risk,” the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
FDA Issues Safety Alert for Impella Left-Sided Blood Pump
MONDAY, April 1, 2024 -- The U.S. Food and Drug Administration has issued a warning regarding a heart pump that could perforate a wall in the left ventricle if used...
Use of Transcatheter Aortic Valve Replacement Up in Adults Younger Than 60
TUESDAY, Feb. 13, 2024 -- For patients aged younger than 60 years, transcatheter aortic valve replacement (TAVR) is increasingly used and has overtaken surgical aortic valve...
Updated Guidelines Issued for Assessing Prosthetic Heart Valves
TUESDAY, Jan. 16, 2024 -- In guidelines issued by the American Society of Echocardiography and published online in the January issue of the Journal of the American Society of...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.